Any 0 3 0 3 O
chemotherapy 4 16 4 16 B-treatment
, 16 17 16 17 O
immunomodulatory 18 34 18 34 B-treatment
drug 35 39 35 39 I-treatment
therapy 40 47 40 47 I-treatment
, 47 48 47 48 O
antineoplastic 49 63 49 63 B-treatment
hormonal 64 72 64 72 I-treatment
therapy 73 80 73 80 I-treatment
, 80 81 80 81 O
immunosuppressive 82 99 82 99 B-treatment
therapy 100 107 100 107 I-treatment
, 107 108 107 108 O
corticosteroids 109 124 109 124 O
> 125 126 125 126 O
20 127 129 127 129 B-lower_bound
mg 130 132 130 132 I-lower_bound
/ 132 133 132 133 I-lower_bound
day 133 136 133 136 I-lower_bound
prednisone 137 147 137 147 B-treatment
or 148 150 148 150 O
equivalent 151 161 151 161 O
( 162 163 162 163 O
unless 163 169 163 169 O
administered 170 182 170 182 O
to 183 185 183 185 O
prevent 186 193 186 193 O
contrast 194 202 194 202 O
material 203 211 203 211 O
reactions 212 221 212 221 O
during 222 228 222 228 O
radiographic 229 241 229 241 B-treatment
procedures 242 252 242 252 I-treatment
) 252 253 252 253 O
, 253 254 253 254 O
or 255 257 255 257 O
growth 258 264 258 264 O
factor 265 271 265 271 O
treatment 272 281 272 281 O
( 282 283 282 283 O
e.g. 283 287 283 287 O
, 287 288 287 288 O
erythropoietin 289 303 289 303 O
) 303 304 303 304 O
within 305 311 305 311 O
14 312 314 312 314 B-upper_bound
days 315 319 315 319 I-upper_bound
before 320 326 320 326 O
first 327 332 327 332 O
NEV801 333 339 333 339 O
dose 340 344 340 344 O

Any 0 3 345 348 O
severe 4 10 349 355 O
, 10 11 355 356 O
acute 12 17 357 362 O
, 17 18 362 363 O
or 19 21 364 366 O
chronic 22 29 367 374 O
medical 30 37 375 382 O
or 38 40 383 385 O
psychiatric 41 52 386 397 B-chronic_disease
condition 53 62 398 407 I-chronic_disease
, 62 63 407 408 O
or 64 66 409 411 O
laboratory 67 77 412 422 O
abnormality 78 89 423 434 O
that 90 94 435 439 O
may 95 98 440 443 O
increase 99 107 444 452 O
the 108 111 453 456 O
risk 112 116 457 461 O
associated 117 127 462 472 O
with 128 132 473 477 O
study 133 138 478 483 O
participation 139 152 484 497 O
or 153 155 498 500 O
NEV801 156 162 501 507 B-treatment
administration 163 177 508 522 O
; 177 178 522 523 O
that 179 183 524 528 O
may 184 187 529 532 O
interfere 188 197 533 542 O
with 198 202 543 547 O
the 203 206 548 551 O
informed 207 215 552 560 O
consent 216 223 561 568 O
process 224 231 569 576 O
or 232 234 577 579 O
with 235 239 580 584 O
compliance 240 250 585 595 O
with 251 255 596 600 O
the 256 259 601 604 O
requirements 260 272 605 617 O
of 273 275 618 620 O
the 276 279 621 624 O
study 280 285 625 630 O
; 285 286 630 631 O
or 287 289 632 634 O
that 290 294 635 639 O
may 295 298 640 643 O
interfere 299 308 644 653 O
with 309 313 654 658 O
the 314 317 659 662 O
interpretation 318 332 663 677 O
of 333 335 678 680 O
study 336 341 681 686 O
results 342 349 687 694 O
and 350 353 695 698 O
, 353 354 698 699 O
in 355 357 700 702 O
the 358 361 703 706 O
Investigator 362 374 707 719 O
's 374 376 719 721 O
opinion 377 384 722 729 O
, 384 385 729 730 O
would 386 391 731 736 O
make 392 396 737 741 O
the 397 400 742 745 O
subject 401 408 746 753 O
inappropriate 409 422 754 767 O
for 423 426 768 771 O
entry 427 432 772 777 O
into 433 437 778 782 O
this 438 442 783 787 O
study 443 448 788 793 O

ECOG 0 4 794 798 B-clinical_variable
performance 5 16 799 810 I-clinical_variable
status 17 23 811 817 I-clinical_variable
of 24 26 818 820 O
0 27 28 821 822 B-lower_bound
or 29 31 823 825 O
1 32 33 826 827 B-upper_bound

Known 0 5 828 833 O
HIV 6 9 834 837 B-chronic_disease
infection 10 19 838 847 I-chronic_disease
or 20 22 848 850 O
AIDS 23 27 851 855 B-chronic_disease
- 27 28 855 856 I-chronic_disease
related 28 35 856 863 I-chronic_disease
illness 36 43 864 871 I-chronic_disease

Life 0 4 872 876 B-clinical_variable
expectancy 5 15 877 887 I-clinical_variable
< 16 17 888 889 O
12 18 20 890 892 B-upper_bound
weeks 21 26 893 898 I-upper_bound

Major 0 5 899 904 B-treatment
surgery 6 13 905 912 I-treatment
within 14 20 913 919 O
28 21 23 920 922 B-upper_bound
days 24 28 923 927 I-upper_bound
before 29 35 928 934 O
the 36 39 935 938 O
first 40 45 939 944 O
NEV801 46 52 945 951 O
dose 53 57 952 956 O

Male 0 4 957 961 B-gender

Men 0 3 962 965 B-gender
who 4 7 966 969 O
partner 8 15 970 977 O
with 16 20 978 982 O
a 21 22 983 984 O
woman 23 28 985 990 B-gender
of 29 31 991 993 O
childbearing 32 44 994 1006 O
potential 45 54 1007 1016 O
, 54 55 1016 1017 O
unless 56 62 1018 1024 O
they 63 67 1025 1029 O
agree 68 73 1030 1035 O
to 74 76 1036 1038 O
use 77 80 1039 1042 B-contraception_consent
2 81 82 1043 1044 I-contraception_consent
effective 83 92 1045 1054 I-contraception_consent
contraceptive 93 106 1055 1068 I-contraception_consent
methods 107 114 1069 1076 I-contraception_consent
( 115 116 1077 1078 O
i.e. 116 120 1078 1082 O
, 120 121 1082 1083 O
a 122 123 1084 1085 O
condom 124 130 1086 1092 B-contraception_consent
, 130 131 1092 1093 O
female 132 138 1094 1100 B-gender
partner 139 146 1101 1108 I-gender
using 147 152 1109 1114 O
oral 153 157 1115 1119 O
, 157 158 1119 1120 O
injectable 159 169 1121 1131 B-contraception_consent
, 169 170 1131 1132 O
or 171 173 1133 1135 O
barrier 174 181 1136 1143 B-contraception_consent
method 182 188 1144 1150 I-contraception_consent
) 188 189 1150 1151 O
while 190 195 1152 1157 O
on 196 198 1158 1160 O
study 199 204 1161 1166 O
drug 205 209 1167 1171 O
and 210 213 1172 1175 O
for 214 217 1176 1179 O
3 218 219 1180 1181 O
months 220 226 1182 1188 O
afterward 227 236 1189 1198 O

Pregnant 0 8 1199 1207 B-pregnancy
or 9 11 1208 1210 O
lactating 12 21 1211 1220 O
female 22 28 1221 1227 B-gender

Presence 0 8 1228 1236 O
of 9 11 1237 1239 O
an 12 14 1240 1242 O
acute 15 20 1243 1248 O
or 21 23 1249 1251 O
chronic 24 31 1252 1259 O
toxicity 32 40 1260 1268 O
of 41 43 1269 1271 O
prior 44 49 1272 1277 O
chemotherapy 50 62 1278 1290 B-treatment
, 62 63 1290 1291 O
with 64 68 1292 1296 O
the 69 72 1297 1300 O
exception 73 82 1301 1310 O
of 83 85 1311 1313 O
alopecia 86 94 1314 1322 B-chronic_disease
, 94 95 1322 1323 O
that 96 100 1324 1328 O
has 101 104 1329 1332 O
not 105 108 1333 1336 O
resolved 109 117 1337 1345 O
to 118 120 1346 1348 O
â‰¤ 121 122 1349 1350 O
Grade 123 128 1351 1356 B-upper_bound
1 129 130 1357 1358 I-upper_bound
, 130 131 1358 1359 O
according 132 141 1360 1369 O
to 142 144 1370 1372 O
the 145 148 1373 1376 O
NCI 149 152 1377 1380 O
CTCAE 153 158 1381 1386 O
v4.03 159 164 1387 1392 O

Radiotherapy 0 12 1393 1405 B-treatment
within 13 19 1406 1412 O
28 20 22 1413 1415 B-upper_bound
days 23 27 1416 1420 I-upper_bound
before 28 34 1421 1427 O
the 35 38 1428 1431 O
first 39 44 1432 1437 O
NEV801 45 51 1438 1444 B-treatment
dose 52 56 1445 1449 O

Receipt 0 7 1450 1457 O
of 8 10 1458 1460 O
more 11 15 1461 1465 O
than 16 20 1466 1470 O
5 21 22 1471 1472 B-lower_bound
prior 23 28 1473 1478 B-treatment
regimens 29 37 1479 1487 I-treatment
of 38 40 1488 1490 I-treatment
cytotoxic 41 50 1491 1500 I-treatment
chemotherapy 51 63 1501 1513 I-treatment
( 64 65 1514 1515 O
unless 65 71 1515 1521 O
prior 72 77 1522 1527 O
approval 78 86 1528 1536 O
is 87 89 1537 1539 O
granted 90 97 1540 1547 O
by 98 100 1548 1550 O
the 101 104 1551 1554 O
Sponsor 105 112 1555 1562 O
) 112 113 1562 1563 O

female 0 6 1564 1570 B-gender
at 7 9 1571 1573 O
least 10 15 1574 1579 O
18 16 18 1580 1582 B-lower_bound
years 19 24 1583 1588 I-lower_bound
of 25 27 1589 1591 O
age 28 31 1592 1595 B-age

